Upcoming Deadline: Berger Montague Encourages Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Shareholders to Reach Out to the Firm by September 24, 2025
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company specialising in oncology treatments, is under investigation for alleged securities fraud. National plaintiffs' law firm Berger Montague PC is leading the investigation.
The investigation concerns common shares of Spectrum purchased or acquired between March 17, 2022, and September 22, 2022. The indictment against Spectrum Pharmaceuticals, Inc. for this period pertains to alleged false or misleading statements about the Pinnacle study and the drug poziotinib. However, specific details about the background or the allegations against Spectrum during this timeframe and regarding this subject are currently not available.
If you are a Spectrum investor and would like to learn more about this action, you can click here or contact Berger Montague. Andrew Abramowitz, Senior Counsel at Berger Montague, can be reached at (215) 875-3015 or [email protected]. Caitlin Adorni, also at Berger Montague, can be reached at (267) 764-4865 or [email protected].
It is important to note that Berger Montague has been a pioneer in securities class action litigation since its founding in 1970. The firm has represented individual and institutional investors for over five decades. Based in Philadelphia, Minneapolis, Delaware, Washington D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto, Berger Montague is a national plaintiffs' law firm with a strong track record in securities fraud cases.
The class action lawsuit alleges false or misleading statements regarding Spectrum's Pinnacle Study, a clinical trial involving poziotinib. The deadline for investors to seek appointment as a lead plaintiff representative is September 24, 2025.
This investigation is ongoing, and more information will be made available as it becomes available. If you have any questions or would like to discuss this matter further, please do not hesitate to contact Berger Montague or visit their website for updates.
%20Shareholders%20to%20Reach%20Out%20to%20the%20Firm%20by%20September%2024%2C%202025){kind=link}